Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
2
×
investing
2
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
alphabet
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
boulder/denver blog main
boulder/denver top stories
brexanolone
broad institute of harvard and mit
brook byers
camp4 therapeutics
cancer
cancer immunotherapy
charles chu
clinical trials
crispr
crispr cas14
crispr therapeutics
crispr-cas9
decheng capital
denali therapeutics
detroit blog main
detroit top stories
diagnostic
eidos therapeutics
estradiol
f-star gamma
fda
food and drug administration
What
today
2
×
ahead
ambien
american
annual
asco
attendees
attention
available
based
big
bio
biosciences
biotech
camp’s
cancer
cas
cash
cheaper
chicago
city
clinical
combinations
community’s
crispr
days
develop
diagnostics
drug
expanding
expects
faster
focus
home
key
kicks
mammoth
meeting
oncology
oncology’s
Language
unset
Current search:
investing
×
today
×
deals
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More